儿童葡萄膜炎性青光眼引流装置手术结局
回顾性介入病例系列评估36例(50眼)儿童葡萄膜炎性青光眼行青光眼引流装置(GDD)植入的结局。平均随访113±61个月,1年、5年、15年累积成功率分别为0.98、0.87、0.59;眼压从31.4±7.5 mmHg显著降至14.4±5.1 mmHg(P<.0001),抗青光眼药物从3.5±1.0种降至1.1±1.3种(P<.0001),视力保持稳定(P=.49)。作者认为难治性儿童葡萄膜炎性青光眼可通过GDD植入成功治疗。
要点
- GDD植入后眼压从31.4±7.5 mmHg降至14.4±5.1 mmHg(P<.0001)。
- 1年、5年、15年累积成功率分别为0.98、0.87、0.59。
- 术后并发症发生率为36%,包括低眼压22%、引流管暴露6%等。
核心结论
- 难治性儿童葡萄膜炎性青光眼可通过GDD植入成功治疗。
- 处理青光眼或原发病后果的进一步干预常见,多数病例视力功能得以维持。
研究设计与样本
- 回顾性介入病例系列,纳入36例(50眼)葡萄膜炎性青光眼儿童行GDD植入。
- 手术时平均年龄10.1±3.1岁(范围5-17岁),平均随访113±61个月(范围8-228个月)。
- 成功定义为眼压≥5且≤21 mmHg;失败定义为末次随访时眼压超出成功标准且视力为无光感,或需进一步青光眼手术(不包括取出管腔内支架缝线或针刺)。
主要发现
- 平均累积成功率(95%CI)为1年0.98(0.86-1.00)、5年0.87(0.73-0.94)、15年0.59(0.32-0.78)。
- 14根引流管判定为失败,其中12根因眼压失控(11眼需第二次GDD植入),1眼因底板暴露取出引流管,1眼丧失光感。
- 术后并发症发生于36%的患者,包括低眼压(22%)、引流管暴露(6%)、引流管阻塞(4%)、角膜失代偿(2%)和黄斑囊样水肿(2%)。
- 视力保持稳定(术前0.35±0.42 vs 术后0.45±0.67,P=.49)。
- 眼压从31.4±7.5 mmHg显著降至14.4±5.1 mmHg(P<.0001),抗青光眼药物数量从3.5±1.0种降至1.1±1.3种(P<.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate outcomes of glaucoma drainage device (GDD) implantation children with uveitic glaucoma. DESIGN: Retrospective interventional case series. METHODS: Success was defined as intraocular pressure (IOP) ≥5 and ≤21 mm Hg. Failure was defined at final follow-up when the IOP was outside the success criterion, and visual function was no perception of light or if further glaucoma surgery (excluding removal of intraluminal stent suture or needling) was required. RESULTS: Fifty eyes of 36 children with uveitic glaucoma underwent GDD implantation. Mean age at surgery was 10.1±3.1 years (range 5-17) with a mean follow-up of 113±61 months (range 8-228). Mean cumulative probabilities of success (95% CI) were 0.98 (0.86-1.00) at 1 year, 0.87 (0.73-0.94) at 5 years, and 0.59 (0.32-0.78) at 15 years. Fourteen tubes were classified as failed, with 12 due to uncontrolled IOP (11 eyes required a second GDD); 1 eye, removal of the tube due to plate exposure; and 1 eye, lost light perception. Postoperative complications occurred in 36% of patients and included hypotony (22%), tube exposure (6%), tube obstruction (4%), corneal decompensation (2%), and cystoid macular edema (2%). Visual acuity remained stable (preoperation 0.35±0.42 vs postoperation 0.45±0.67, P = .49). IOP was significantly reduced from 31.4±7.5 mm Hg to 14.4±5.1 mm Hg (P < .0001) as were the number of glaucoma medications 3.5±1.0 vs 1.1±1.3 (P < .0001). CONCLUSIONS: Refractory pediatric uveitic glaucoma can be treated successfully by GDD implantation. Further interventions to manage consequences of glaucoma or the underlying disease are common, and visual function is maintained in the majority of cases.
引用
- Gkaragkani E, Jayaram H, Papadopoulos M, et al. Glaucoma Drainage Device Surgery Outcomes in Children With Uveitic Glaucoma. Am J Ophthalmol. 2023. PMID: 36822573. doi:10.1016/j.ajo.2023.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。